PRAGUE-19 study update

Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update

Petr Toušek1, MD, PhD; Viktor Kočka1*, MD, PhD; Martin Malý2, MD, PhD;
Martin Kozel1, MD; Robert Petr1, MD; Martin Hajsl2, MD; Jiří Jarkovský3, MSc, PhD;
Libor Lisa1, MD; Tomáš Buděšínský1, MD; Petr Widimský1, MD, PhD

                                            Three-year optical coherence tomography imaging.

Impact on daily practice
It is reassuring for interventional cardiologists performing often challenging pPCI that the first long-term clinical follow-up results of BVS in this setting are encouraging. It seems safe to reduce antiplatelet medication to a single agent after 12 months. Invasive imaging after three years demonstrated visible scaffold struts, good arterial healing and minimal late lumen loss.